drugset / Trial / NCT01873378

GnRH Agonist Pretreatment in Hysteroscopic Myomectomy

NCT01873378

RandomizedParallel-groupSingle-blindTreatment

Summary

The primary outcome of this study is to assess if the GnRHa administration before cold loop hysteroscopic myomectomy contributes to accomplish the treatment in only one surgical procedure. Moreover, we will investigate the intraoperative influence of such pharmacologic therapy in terms of distension liquid absorption and duration of the procedures.

Timeline

Start
2013-01
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Triptorelin Other / unclassified 3.75 mg Intramuscular

Indications